Similar articles

• Effect of long-term administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) content in mice.

  Saitoh T, Mizuno Y, Nagatsu T, Yoshida M. Saitoh T, et al. Neurosci Lett. 1988 Oct 17;92(3):321-4. doi: 10.1016/0304-3940(88)90610-6. Neurosci Lett. 1988. PMID: 3200488
• Rapid post mortem changes in 3,4-dihydroxyphenylacetic acid (DOPAC), a dopamine metabolite, in rat striatum.

  Moleman P, Bruinvels J, Westerink BH. Moleman P, et al. J Neurochem. 1977 Jul;29(1):175-7. doi: 10.1111/j.1471-4159.1977.tb03942.x. J Neurochem. 1977. PMID: 886321 No abstract available.
• Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels.

  Meller E, Friedhoff AJ, Friedman E. Meller E, et al. Life Sci. 1980 Feb 18;26(7):541-7. doi: 10.1016/0024-3205(80)90317-3. Life Sci. 1980. PMID: 7366335 No abstract available.
• The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats.

  Persson SA. Persson SA. Eur J Pharmacol. 1977 May 1;43(1):73-83. doi: 10.1016/0014-2999(77)90162-5. Eur J Pharmacol. 1977. PMID: 16756
• Failure of morphine to increase striatal 3,4-dihydroxyphenylacetic acid in fasted rats.

  De Montis GM, Olianas MC, Di Lorenzo C, Tagliamonte A. De Montis GM, et al. Eur J Pharmacol. 1978 Jan 1;47(1):121-3. doi: 10.1016/0014-2999(78)90382-5. Eur J Pharmacol. 1978. PMID: 618726